WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007009012) COMPOSITIONS FOR ORAL ADMINISTRATION OF SUSTAINED RELEASE GLUTATHIONE, METHODS FOR THEIR PRODUCTION AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/009012    International Application No.:    PCT/US2006/027126
Publication Date: 18.01.2007 International Filing Date: 13.07.2006
IPC:
A61K 9/16 (2006.01), A61K 31/195 (2006.01), A61K 38/06 (2006.01), A61K 31/198 (2006.01), A61K 47/32 (2006.01), A61K 47/38 (2006.01)
Applicants: CZAP, Al [US/US]; (US)
Inventors: CZAP, Al; (US)
Agent: DOWELL, Ralph, A.; Dowell & Dowell, P.C., Suite 406, 2111 Eisenhower Avenue, Alexandria, VA 22314 (US)
Priority Data:
60/698,478 13.07.2005 US
Title (EN) COMPOSITIONS FOR ORAL ADMINISTRATION OF SUSTAINED RELEASE GLUTATHIONE, METHODS FOR THEIR PRODUCTION AND USES THEREOF
(FR) COMPOSITIONS POUR ADMINISTRATION PAR VOIE ORALE DE GLUTATHIONE A LIBERATION SOUTENUE, LEURS PROCEDES DE PRODUCTION ET D'UTILISATION
Abstract: front page image
(EN)A composition suitable for oral administration for sustained-release of glutathione, the composition comprising from about 50 % by weight to about 90 % by weight glutathione; from about 0 % by weight to about 10 % by weight binder; from about 10 % by weight to about 50 % by weight of at least one sustained release agent; and a granule size of from about 850 μm to about 5000 μm, is provided. Methods for preparing such compositions are also provided. Uses and methods of medical treatment comprising orally administering a composition for sustained release of glutathione to a patient suffering from or at risk of suffering from a neurological disorder are also provided.
(FR)L'invention concerne une composition appropriée pour administration par voie orale de glutathione à libération soutenue. Ladite composition comprend entre environ 50 % en poids et environ 90 % en poids de glutathione, entre environ 0 % en poids et environ 10 % en poids de liant; entre environ 10 % en poids et environ 50 % en poids d'au moins un agent de libération soutenue; la taille des granules est comprise entre environ 850 μm et environ 5000 μm. L'invention concerne également des procédés de préparation de ces compositions. Elle concerne enfin leurs utilisations et les procédés de traitement médical consistant à administrer par voie orale à un patient souffrant ou risquant de souffrir d'un trouble neurologique une composition de glutathione à libération soutenue.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)